Detailed information for compound 147271

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 233.22 | Formula: C12H11NO4
  • H donors: 1 H acceptors: 2 LogP: 2.06 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(CC=C)cc2c1oc(=O)c(=O)[nH]2
  • InChi: 1S/C12H11NO4/c1-3-4-7-5-8-10(9(6-7)16-2)17-12(15)11(14)13-8/h3,5-6H,1,4H2,2H3,(H,13,14)
  • InChiKey: HWSCXELFFKDRIE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Loa Loa (eye worm) hypothetical protein 0.0298 0.2285 0.166
Trichomonas vaginalis glucosylceramidase, putative 0.0213 0.102 0.1027
Brugia malayi Glycosyl hydrolases family 31 protein 0.0605 0.6863 1
Loa Loa (eye worm) trehalase 0.0298 0.2285 0.166
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Loa Loa (eye worm) glycosyl hydrolase family 31 protein 0.0605 0.6863 0.6609
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Echinococcus multilocularis lysosomal alpha glucosidase 0.0605 0.6863 1
Mycobacterium ulcerans glycosyl hydrolase 0.0144 0 0.5
Schistosoma mansoni alpha-glucosidase 0.0605 0.6863 1
Trichomonas vaginalis conserved hypothetical protein 0.0298 0.2285 0.9054
Mycobacterium leprae Possible hydrolase 0.0144 0 0.5
Onchocerca volvulus 0.0298 0.2285 0.4681
Schistosoma mansoni alpha-glucosidase 0.0605 0.6863 1
Brugia malayi O-Glycosyl hydrolase family 30 protein 0.0308 0.2434 0.0326
Onchocerca volvulus 0.0298 0.2285 0.4681
Onchocerca volvulus 0.0298 0.2285 0.4681
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Loa Loa (eye worm) hypothetical protein 0.0298 0.2285 0.166
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Loa Loa (eye worm) hypothetical protein 0.0298 0.2285 0.166
Onchocerca volvulus 0.0407 0.3906 1
Trichomonas vaginalis glucosylceramidase, putative 0.0213 0.102 0.1027
Trypanosoma brucei glycosyl hydrolase, putative 0.0144 0 0.5
Loa Loa (eye worm) O-glycosyl hydrolase family 30 protein 0.0308 0.2434 0.1822
Onchocerca volvulus Trehalase homolog 0.0298 0.2285 0.4681
Loa Loa (eye worm) trehalase 0.0298 0.2285 0.166
Trichomonas vaginalis trehalase, putative 0.0298 0.2285 0.9054
Mycobacterium tuberculosis Conserved protein 0.0144 0 0.5
Loa Loa (eye worm) trehalase 0.0298 0.2285 0.166
Onchocerca volvulus 0.0298 0.2285 0.4681
Echinococcus multilocularis lysosomal alpha glucosidase 0.0605 0.6863 1
Loa Loa (eye worm) TRE-1 protein 0.0298 0.2285 0.166
Trypanosoma cruzi glycosyl hydrolase, putative 0.0144 0 0.5
Leishmania major glycosyl hydrolase, putative 0.0144 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0298 0.2285 0.166
Loa Loa (eye worm) TRE-2 protein 0.0298 0.2285 0.166
Onchocerca volvulus 0.0298 0.2285 0.4681
Echinococcus granulosus lysosomal alpha glucosidase 0.0605 0.6863 1
Trichomonas vaginalis glucosylceramidase, putative 0.0308 0.2434 1
Loa Loa (eye worm) hypothetical protein 0.0298 0.2285 0.166
Loa Loa (eye worm) hypothetical protein 0.0382 0.3538 0.3015

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 7 mg kg-1 Effective dose against passive cutaneous anaphylaxis when administered perorally. ChEMBL. 2578192
I50 (functional) = 10 uM Concentration required to inhibit antigen-induced release of histamine (AIR) by 50% from passively sensitized rat mast cells ChEMBL. 2578192
Inhibition (functional) = 77 % Inhibition of antigen-induced release of histamine at a dose of 25 mg/kg in passive cutaneous anaphylaxis in the male Sprague-Dawley rats ChEMBL. 2578192

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.